Advertisement

Topics

Anju Software Acquires Sylogent to Enter Publication Planning and Clinical Disclosure Segments

12:30 EDT 21 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired the assets of Sylogent. “Sylogent has cloud based state of the art software solutions that enhance current Anju ...

Other Sources for this Article

Anju Software
Kurien Jacob, 480-326-2358
kurien@anjusoftware.com
or
Sylogent
Jack Yeager, 310-890-1944
or
Providence Equity
Sard Verbinnen & Co
Andrew Cole / Kelsey Markovich, 212-687-8080
Prov-SVC@SARDVERB.com

NEXT ARTICLE

More From BioPortfolio on "Anju Software Acquires Sylogent to Enter Publication Planning and Clinical Disclosure Segments"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...